New Orleans, March 13–15, 2023 — NINGBO KONFOONG BIOINFORMATION TECH CO., LTD. (KFBIO) showcased its latest digital pathology technologies at USCAP 2023.

The company presented the KFBIO 5-Slide Scanner and the KFBIO 120-Slide Scanner. These solutions help pathology laboratories accelerate digital transformation and improve workflow efficiency.

As one of the world’s largest pathology conferences, USCAP attracted thousands of pathology professionals and industry experts.

New Achievement and New Record

USCAP 2023 provided an excellent opportunity for KFBIO to demonstrate its latest digital pathology scanner innovations. KFBIO remains committed to developing advanced and reliable digital pathology solutions. The company has significantly improved scanner performance. The latest scanners can capture a 15 mm × 15 mm area at 20× magnification in just 15 seconds. This milestone reflects the dedication and expertise of the KFBIO research and development team.

At the same time, KFBIO has gained extensive experience in deploying digital pathology scanners worldwide. The company has also strengthened its capabilities in implementing end-to-end digital pathology solutions.

During USCAP 2023, the KFBIO booth achieved a record number of visitors. The strong interest demonstrated the growing adoption of digital pathology across the industry. KFBIO’s overseas team, led by Overseas Marketing Director Vito Wang, welcomed visitors from around the world. The team engaged in detailed discussions with customers and industry professionals. Visitors experienced KFBIO digital pathology scanners through live demonstrations.

The team also introduced KFBIO’s comprehensive digital pathology solution. Both new and existing customers highly praised the scanner’s improved speed. Visitors also recognized its stability and high-resolution image quality.

Innovations lead the digital pathology future

Over the past decade, KFBIO has developed pathology products across five major areas. These areas include digital pathology scanners, pathology AI products, pathology information systems, routine pathology equipment, and diagnostic services.

KFBIO provides a complete digital pathology solution that integrates both software and hardware. These solutions address the diverse needs of hospitals, laboratories, and research institutions.

To support different applications, KFBIO offers multiple scanner models.

• Low-throughput scanners support remote pathology services.
• High-throughput scanners support fully digital pathology departments.
• Brightfield and fluorescence slide scanners support scientific research applications.
• KFBIO is also developing an ultra-high-throughput scanner capable of handling 1,000 slides.
• In addition, oil immersion scanners are expected to be completed by the end of 2023.

The KFBIO digital pathology slide scanner remains the company’s flagship product. It scans a 15 mm × 15 mm area at 20× magnification in only 15 seconds. The scanner maintains a one-time scanning success rate above 99.8%. It also produces high-resolution digital pathology images. The system supports continuous scanning of both brightfield and fluorescence slides on a single platform. Users can customize and upgrade fluorescence channels according to specific requirements.

Looking Ahead

USCAP 2023 concluded successfully, and KFBIO appreciates the support and attention received during the event. The conference marked an important step in KFBIO’s global market expansion strategy. KFBIO will continue participating in major pathology conferences worldwide throughout 2023.

We sincerely invite you to connect with us and explore the future of digital pathology together.